Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,532.7
17.0 (0.68%)

 

  • STI Straits Times Index
    2,532.7
    17.0 (0.68%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,568.1
    -7.8 (-0.50%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,102.5
    155.9 (0.62%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,377.6
    5.9 (0.17%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,514.8
    -58.8 (-0.26%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,127.1
    52.0 (1.03%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,493.1M
  • Value: 1,391.4M
  • Rise: 221
  • Fall: 111
  • Unch: 476

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.186+0.003
Leader Env0.064+0.008
AnAn Intl0.043+0.008
Synagie0.194+0.005
LionGold0.002-
Genting Sing0.710-0.020
Medtecs Intl1.010+0.025
ISDN0.370+0.070
CNMC Goldmine0.355+0.045
Anchor Resources0.009+0.002

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,246.6 -303.4
HSCEI 9,742.1 -111.1
Jakarta 4,863.1 -41.0
Nikkei 225 22,062.1 -450.0
SSE Comp 2,958.7 -11.9
Shanghai A 3,101.3 -12.4
Shanghai B 211.6 -1.8
KOSPI 2,098.0 -36.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Medtecs Intl MEDTECS INTERNATIONAL CORP LTD
Quotes 10 Minutes Delayed. Updated at 05 Aug 2020 17:15
Last (SGD): 1.010 Change: +0.025 High: 1.050 Remarks: -
Change (%): +2.54 Low: 0.980
Open 0.990 Yesterday's Close 0.985
Buy Price 1.010 Sell Price 1.020
Buy Volume ('000) 1,553.5 Sell Volume ('000) 694.2
Cumulative Volume ('000) 36,902.1 Cumulative Value 37,618,775
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a 0.00285 Trailing EPS (SGD) e 0.00285 NAV (SGD) b 0.1559
PE a 354.386 Trailing PE f 354.571 Price / NAV b 6.4785
Dividend (SGD) d - Cash In Hand (SGD) g 0.0075 Issued & Paid-up Shares c 549,411,000
Dividend Yield (%) d - Price / Cash In Hand g 134.667 Treasury Shares h -
Beta - 75 Daysi 0.655 R-Squared - 75 Days(%)i 0.97 Market Cap (M) 554.905
Beta - 500 Daysi -0.225 R-Squared - 500 Days (%)i 0.05 Enterprise Value (M) 607.605
Piotroski F Score 7 Exchange Code 546 Par Value ( USD ) n.a.
52 Weeks Volatility (%) 139.5941 6-Month VWAP 0.294 Free Float (%) -
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Manufacturing - Medical Specialties
Category Classification Medical & Biotechnology
Index Components FTSE ST Catalist Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 16 Apr 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Medtecs Intl SGX 554.905 354.386 354.571 6.4785 -
Industry Medical & Biotechnology SGX 936.802 20.744 18.988 1.2916 2.048
Medical Specialties SGX 4,373.501 223.787 125.505 20.4019 0.242
Index FTSE ST Catalist Index SGX 74.832 30.063 88.683 0.9379 1.877
Local Peer Top Glove SGX 24,871.133 204.082 116.125 22.6657 0.254
Local Peer UG Healthcare SGX 645.146 257.433 317.181 15.1893 0.078
Local Peer Biolidics SGX 109.350 - - 10.0478 -
Local Peer Yunnan Energy SGX 43.794 - - 0.9014 -
Local Peer Annica SGX 16.675 - - 3.3333 -
Global Peer ABBOTT LABORATORIES NYSE 176,929.063 48.262 57.575 5.7862 1.315
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 164,454.259 44.495 44.375 5.5047 0.184
Global Peer DANAHER CORP NYSE 146,187.913 58.738 50.046 4.4307 0.324
Global Peer MEDTRONIC PLC NYSE 129,153.777 26.969 26.969 2.5456 2.243
Global Peer BECTON DICKINSON & CO NYSE 80,184.870 74.108 88.115 3.8276 1.045
Global Peer INTUITIVE SURGICAL INC NASDAQ 79,987.271 57.991 70.411 9.1513 -
Global Peer STRYKER CORP NYSE 71,102.216 34.135 44.411 5.5749 1.125
Global Peer BOSTON SCIENTIFIC CORP NYSE 53,077.319 11.293 13.336 - -
Global Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 48,130.930 36.849 43.198 3.9128 1.697
Global Peer EDWARDS LIFESCIENCES CORP NYSE 47,625.361 45.492 64.047 12.4053 -
Other Global Peers DEXCOM INC (NASDAQ), BAXTER INTERNATIONAL INC (NYSE), IDEXX LABORATORIES INC (NASDAQ), AGILENT TECHNOLOGIES INC (NYSE), ALCON AG (NYSE), RESMED INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), ALIGN TECHNOLOGY INC (NASDAQ), METTLER-TOLEDO INTERNATIONAL INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), HOLOGIC INC (NASDAQ), TOPGLOV (Bursa), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), TELEFLEX INC (NYSE), HARTA (Bursa), VARIAN MEDICAL SYSTEMS INC (NYSE), COOPER COS INC (NYSE), BIO RAD LABORATORIES INC (NYSE), FISHER & PAYKEL HEALTHCARE CORP (ASX), ABIOMED INC (NASDAQ), INSULET CORPORATION (NASDAQ), PERKINELMER INC (NYSE), STERIS PLC (NYSE), WATERS CORP (NYSE), WEIGAO GROUP (HKEx), QUIDEL CORP (NASDAQ), MASIMO CORPORATION (NASDAQ), QIAGEN NV (NYSE), DENTSPLY SIRONA INC (NASDAQ), COCHLEAR LTD (ASX), MICROPORT (HKEx), PENUMBRA INC (NYSE), NOVOCURE LTD (NASDAQ), SUPERMX (Bursa), BRUKER CORPORATION (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), HILL-ROM HOLDINGS INC (NYSE), KANGJI MEDICAL (HKEx), GLOBUS MED INC (NYSE), IRHYTHM TECHNOLOGIES INC (NASDAQ), NEVRO CORP (NYSE), NEOGEN CORP (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), VENUS MEDTECH-B (HKEx), WRIGHT MEDICAL GROUP NV (NASDAQ), HAEMONETICS CORP (NYSE), ICU MEDICAL INC (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), INOVIO PHARMACEUTICALS INC (NASDAQ), AK MEDICAL (HKEx), INARI MEDICAL INC (NASDAQ), NUVASIVE INC (NASDAQ), STAAR SURGICAL CO (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), PEIJIA-B (HKEx), MERIT MEDICAL SYSTEMS (NASDAQ), CONMED CORP (NYSE), EBOS GROUP (ASX), LIVANOVA PLC (NASDAQ), GLAUKOS CORPORATION (NYSE), CANTEL MEDICAL CORP (NYSE), ATRICURE INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), CAREDX INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), AVANOS MEDICAL INC (NYSE), BIOTELEMETRY INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), NANOSONICS LIMITED (ASX), GENMARK DIAGNOSTICS INC (NASDAQ), VAPOTHERM INC (NYSE), MESA LABORATORIES INC (NASDAQ), KDL MEDICAL (HKEx), CERUS CORP (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), ATRION CORP (NASDAQ), INMODE LTD (NASDAQ), CIRC (HKEx), LIFETECH SCI (HKEx), HESKA CORP (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), CRYOLIFE INC (NYSE), VERICEL CORP (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), INOGEN INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), SURMODICS INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), ZYNEX INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), QUOTIENT LTD (NASDAQ), SI BONE INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), VIEWRAY INC (NASDAQ), AXOGEN INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), YESTAR HEALTH (HKEx), MCP INCOME OPPORTUNITIES TRUST (ASX), RETRACTABLE TECHNOLOGIES INC (NYSE American), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), ANGIODYNAMICS INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), PW MEDTECH (HKEx), AROA BIOSURGERY LTD (ASX), STEREOTAXIS INC (NYSE American), ALPHA PRO TECH (NYSE American), GOLDEN MEDITECH (HKEx), PROFOUND MED CORP (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), MEDICAL DEVELOPMENT INTL (ASX), IRADIMED CORP (NASDAQ), CORMEDIX INC (NYSE American), CUTERA INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), INVACARE CORP (NYSE), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), ACCURAY INCORPORATED (NASDAQ), MISONIX INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), SIENTRA INC (NASDAQ), VINCENT MED (HKEx), TELA BIO INC (NASDAQ), DERMTECH INC (NASDAQ), FONAR CORP (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), MODERN DENTAL (HKEx), LKL (Bursa), SOLITON INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), ELECTROMED INC (NYSE American), ATOMO DIAGNOSTICS LIMITED (ASX), NEMAURA MEDICAL INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), BIOMERICA INC (NASDAQ), INTRICOM CORP (NASDAQ), VENUS CONCEPT INC (NASDAQ), VOLITIONRX LIMITED (NYSE American), PAVMED INC (NASDAQ), ELECTROCORE INC (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), CYCLOPHARM LIMITED (ASX), SOMNOMED LIMITED (ASX), NEPHROS INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), ENLIVEX THERAPEUTICS LTD (NASDAQ), DAXOR CORP (NYSE American), SINTX TECHNOLOGIES INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), YUNNAN ENERGY (HKEx), ZOSANO PHARMA CORP (NASDAQ), DIMERIX LTD (ASX), CLEARPOINT NEURO INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), RESPIRI LTD (ASX), SDI LTD (ASX), ONCOCYTE CORP (NYSE American), NEURONETICS INC (NASDAQ), KELFRED (HKEx), IMPEDIMED LIMITED (ASX), COMPUMEDICS (ASX), CONFORMIS INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), MICRO-X LTD (ASX), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), RESONANCE HEALTH LTD (ASX), NEOVASC INC (NASDAQ), CELSION CORPORATION (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), IMMUCELL CORP (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), CHF SOLUTIONS INC (NASDAQ), INCANNEX HEALTHCARE LTD (ASX), ATOSSA THERAPEUTICS INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), NOVA EYE MEDICAL LIMITED (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), LBT INNOVATIONS LTD (ASX), IMAGION BIOSYSTEMS LIMITED (ASX), AKERS BIOSCIENCES INC (NASDAQ), OVENTUS MEDICAL LTD (ASX), IRIDEX CORP (NASDAQ), NEUROTROPE INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), AVINGER INC (NASDAQ), LIFE HEALTHCARE (HKEx), PREDICTIVE ONCOLOGY INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), USCOM LTD (ASX), METALICITY LIMITED (ASX), CARDIEX LTD (ASX), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), BIOLASE INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), CHECK-CAP LTD (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), TENAX THERAPEUTICS INC (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), OPTISCAN IMAGING (ASX), MYOS RENS TECHNOLOGY INC (NASDAQ), CYANOTECH CORP (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE), NANOVIBRONIX INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), ADHERIUM LIMITED (ASX), HANCOCK JAFFE LABORATORIES INC (NASDAQ), DIGIRAD CORP (NASDAQ), DYNATRONICS CORP (NASDAQ), STHAI (SET), VIVEVE MEDICAL INC (NASDAQ), NEUROMETRIX INC (NASDAQ), CANCER GENETICS INC (NASDAQ), ANALYTICA (ASX), HUAKANG BIOMED (HKEx), OBALON THERAPEUTICS INC (NASDAQ), DORSAVI LTD (ASX), INSPIREMD INC (NYSE American), MEDIGARD LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.160
+18.82 %
10 Days -+0.280
+38.36 %
20 Days -+0.190
+23.17 %
Medium Term Return 3 Months -+0.852
+539.24 %
6 Months -+0.909
+900.00 %
1 Year -+0.982
+3507.14 %
Long Term Return 2 Years -+0.972
+2557.89 %
3 Years -+0.960
+1920.00 %
5 Years -+0.961
+1961.22 %
Annualised Return Annualised --
+83.16 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.026 - 1.050 Change From 1 Year Low +0.984 % Change From 1 Year Low (%) +3784.62
Change From 1 Year High -0.040 % Change From 1 Year High (%) -3.81
2 Years Range 0.022 - 1.050 Change From 2 Years Low +0.988 % Change From 2 Years Low (%) +4490.91
Change From 2 Years High -0.040 % Change From 2 Years High (%) -3.81
5 Years Range 0.022 - 1.050 Change From 5 Years Low +0.988 % Change From 5 Years Low (%) +4490.91
Change From 5 Years High -0.040 % Change From 5 Years High (%) -3.81
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The Group's business started in 1989 with the incorporation of Clement Textile & International Corporation in Philippines in 1989. Medtecs is an integrated healthcare product and services provider in Asia Pacific, and a manufacturer and distributor of medical consumables for the healthcare industry. Started in the Philippines in 1989, the Group has established its presence in the United States, Europe and the Asia Pacific region. Today, the Group has offices in Singapore, Hong Kong, Taiwan, the Philippines, Cambodia and China.The Group is an original product manufacturer (OPM) of a wide range of medical consumables for large multinational healthcare distributors, pharmaceutical companies and hospital groups in the United States and Europe. Major product groups manufactured by the Group include linen, hospital apparel, hospital apparel and bandages. The Group’s OPM is supported by 10 manufacturing facilities located in the Philippines (4), China (4) and one each in Cambodia and Taiwan.The Group also acts as agent to distribute other branded medical devices in Asia Paci8fic, including medical supplies and equipment such as wheel chairs, syringes, gauzes, digital thermometers, nebulizers, blood pressure monitors and others.The Group’s Taiwan Depository Receipts (TDR) was listed on the Taiwan Stock Exchange on 13 December 2002.The Company is an investment holding company incorporated in Bermuda on 26 November 1997.

IPO Performance

Listing Date 06 Oct 1999 Full Subscription Rate (x) 10.99
No of Placement Shares (M) 27.00 No of Public Offer Shares (M) 18.00 Public Offer Subscription Rate (x) 25.98
IPO Price (SGD) a 0.251 First Day Close (SGD) a 0.334 First Week Close (SGD) a 0.328
Current vs IPO Price (%) +302.39 First Day Gain (%) +33.07 First Week Gain (%) +30.68
Notes:
  1. Adjusted for the following: Bonus issue 1 for 5 on 29/04/2004

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2019 Dec 2019 Part 1(5.04 MB)
Annual Report 2018 Dec 2018 Part 1(3.96 MB)
Annual Report 2017 Dec 2017 Part 1(3.57 MB)
Part 2(0.45 MB)
Annual Report 2016 Dec 2016 Part 1(2.67 MB)
Annual Report 2015 Dec 2015 Part 1(1.52 MB)
Annual Report 2014 Dec 2014 Part 1(4.00 MB)
Annual Report 2013 Dec 2013 Part 1(3.85 MB)
Annual Report 2012 Dec 2012 Part 1(3.68 MB)
Annual Report 2011 Dec 2011 Part 1(6.92 MB)
Annual Report 2010 Dec 2010 Part 1(3.56 MB)
Annual Report 2009 Dec 2009 Part 1(2.70 MB)
Annual Report 2008 Dec 2008 Part 1(1.48 MB)
Annual Report 2007 Dec 2007 Part 1(3.26 MB)
Part 2(0.02 MB)
Annual Report 2006 Dec 2006 Part 1(7.72 MB)
Annual Report 2005 Dec 2005 Part 1(23.76 MB)
IPO Prospectus
IPO Prospectus 1999 Oct 1999 Part 1(0.12 MB)
Part 2(0.39 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
05 Aug 2020 0.990 1.050 0.980 1.010 36,902,100 1.0194
04 Aug 2020 1.030 1.040 0.945 0.985 45,987,100 0.9934
03 Aug 2020 0.945 1.020 0.945 1.010 76,752,100 0.9803
30 Jul 2020 0.865 0.920 0.850 0.900 50,244,400 0.8949
29 Jul 2020 0.885 0.890 0.840 0.850 34,157,200 0.8649
28 Jul 2020 0.775 0.880 0.770 0.875 84,793,100 0.8214
27 Jul 2020 0.755 0.775 0.745 0.765 16,102,200 0.7614
24 Jul 2020 0.775 0.775 0.740 0.750 12,283,800 0.7554
23 Jul 2020 0.750 0.775 0.745 0.760 32,044,300 0.7644
22 Jul 2020 0.765 0.765 0.725 0.730 17,919,500 0.7442
21 Jul 2020 0.730 0.790 0.690 0.745 66,748,200 0.7493
20 Jul 2020 0.665 0.740 0.645 0.735 93,436,700 0.6985
17 Jul 2020 0.510 0.625 0.495 0.625 68,493,300 0.5693
16 Jul 2020 0.665 0.675 0.520 0.520 39,808,600 0.5879
15 Jul 2020 0.685 0.695 0.595 0.645 34,022,600 0.6572
14 Jul 2020 0.650 0.720 0.605 0.635 57,499,900 0.6502
13 Jul 2020 0.935 0.965 0.560 0.680 136,617,600 0.7854
09 Jul 2020 0.855 0.910 0.845 0.870 79,376,600 0.8785
08 Jul 2020 0.735 0.820 0.710 0.820 77,174,700 0.7600
07 Jul 2020 0.685 0.770 0.650 0.705 109,380,300 0.7020
06 Jul 2020 0.535 0.655 0.530 0.650 80,881,000 0.5799
03 Jul 2020 0.465 0.525 0.460 0.500 98,205,600 0.4914
Summary
Current 2 Weeks
(22 Jul 2020 to 05 Aug 2020)
0.765 1.050 0.725 1.010 407,185,800 -
Previous 2 Weeks
(07 Jul 2020 to 21 Jul 2020)
0.685 1.050 0.650 0.745 762,558,500 -
4 Weeks from
(09 Jun 2020 to 06 Jul 2020)
0.245 1.050 0.230 0.650 1,001,771,100 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.